This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Novartis Ag, Ucb Biopharma Sprl, Ucbbiopharma Srl. Active years: 2019-2022.
Location History:
- Basel, CH (2019)
- Saint Louis-Strasse, CH (2020)
- Slough, GB (2022)
Company Filing History:
1 out of 3,974 
1 out of 139 
1 out of 129 Years Active: 2019-2022
Title: Paul Alfred Smith: Innovator in Biomarkers and Multiple Sclerosis Treatment
Introduction
Paul Alfred Smith is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the development of biomarkers and therapeutic combinations for various diseases. With a total of 3 patents, his work has the potential to impact patient care and treatment outcomes.
Latest Patents
One of his latest patents is titled "Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy." This invention provides the use of lipocalin 2 (LCN2) as a biomarker for IL-17 mediated diseases and for monitoring the response of a patient to anti-IL-17 therapy. Another significant patent is "Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis." This invention relates to combinations and pharmaceutical compositions that include siponimod and laquinimod, aimed at treating multiple sclerosis, particularly secondary progressive multiple sclerosis.
Career Highlights
Throughout his career, Paul has worked with prominent companies in the pharmaceutical industry, including UCB Biopharma and Novartis AG. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Paul has collaborated with esteemed colleagues such as Adam Samuel Platt and Stephen Edward Rapecki. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.
Conclusion
Paul Alfred Smith is a distinguished inventor whose work in biomarkers and multiple sclerosis treatment showcases his commitment to improving healthcare outcomes. His contributions continue to influence the medical field and offer hope for patients worldwide.